212 related articles for article (PubMed ID: 25278236)
1. Synthesis and anti-tumor activity of glycosyl oxadiazoles derivatives.
Du K; Cao X; Zhang P; Zheng H
Bioorg Med Chem Lett; 2014 Nov; 24(22):5318-20. PubMed ID: 25278236
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of 2,5-di(4-aryloylaryloxymethyl)-1,3,4-oxadiazoles as anti-cancer agents.
Gurupadaswamy HD; Girish V; Kavitha CV; Raghavan SC; Khanum SA
Eur J Med Chem; 2013 May; 63():536-43. PubMed ID: 23535322
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anticancer activities of novel 3,5-disubstituted-1,2,4-oxadiazoles.
Kumar D; Patel G; Johnson EO; Shah K
Bioorg Med Chem Lett; 2009 May; 19(10):2739-41. PubMed ID: 19376704
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, molecular modeling and biological evaluation of 2-(benzylthio)-5-aryloxadiazole derivatives as anti-tumor agents.
Liu K; Lu X; Zhang HJ; Sun J; Zhu HL
Eur J Med Chem; 2012 Jan; 47(1):473-8. PubMed ID: 22119130
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of a novel series of 1,3,4-oxadiazole bearing N-methyl-4-(trifluoromethyl)phenyl pyrazole moiety as cytotoxic agents.
Puthiyapurayil P; Poojary B; Chikkanna C; Buridipad SK
Eur J Med Chem; 2012 Jul; 53():203-10. PubMed ID: 22542958
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor evaluation of some new 1,3,4-oxadiazole-based heterocycles.
Bondock S; Adel S; Etman HA; Badria FA
Eur J Med Chem; 2012 Feb; 48():192-9. PubMed ID: 22204901
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and cytotoxicity of bis-1,3,4-oxadiazoles and bis-pyrazoles derived from 1,4-bis[5-thio-4-substituted-1,2,4-triazol-3-yl]-butane and their DNA binding studies.
Purohit M; Prasad VV; Mayur CY
Arch Pharm (Weinheim); 2011 Apr; 344(4):248-54. PubMed ID: 21469174
[TBL] [Abstract][Full Text] [Related]
8. 1,2,4-Oxadiazoles: a new class of anti-prostate cancer agents.
Khatik GL; Kaur J; Kumar V; Tikoo K; Nair VA
Bioorg Med Chem Lett; 2012 Mar; 22(5):1912-6. PubMed ID: 22326399
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, structure, and bioactivity of N'-substituted benzylidene-3,4,5-trimethoxybenzohydrazide and 3-acetyl-2-substituted phenyl-5-(3,4,5-trimethoxyphenyl)-2,3-dihydro-1,3,4-oxadiazole derivatives.
Jin L; Chen J; Song B; Chen Z; Yang S; Li Q; Hu D; Xu R
Bioorg Med Chem Lett; 2006 Oct; 16(19):5036-40. PubMed ID: 16876405
[TBL] [Abstract][Full Text] [Related]
10. New 2-benzylsulfanyl-nicotinic acid based 1,3,4-oxadiazoles: their synthesis and biological evaluation.
Patel NB; Purohit AC; Rajani DP; Moo-Puc R; Rivera G
Eur J Med Chem; 2013 Apr; 62():677-87. PubMed ID: 23434641
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antiproliferative assay of 1,3,4-oxadiazole and 1,2,4-triazole derivatives in cancer cells.
Tu G; Yan Y; Chen X; Lv Q; Wang J; Li S
Drug Discov Ther; 2013 Apr; 7(2):58-65. PubMed ID: 23715503
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel 1,2,4-oxadiazoles and analogues as potential anticancer agents.
Kumar D; Patel G; Chavers AK; Chang KH; Shah K
Eur J Med Chem; 2011 Jul; 46(7):3085-92. PubMed ID: 21481985
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and pro-apoptotic antitumour properties of indole-based 3,5-disubstituted oxadiazoles.
Ziedan NI; Stefanelli F; Fogli S; Westwell AD
Eur J Med Chem; 2010 Oct; 45(10):4523-30. PubMed ID: 20705365
[TBL] [Abstract][Full Text] [Related]
14. Novel 5-(2-hydroxyphenyl)-3-substituted-2,3-dihydro-1,3,4-oxadiazole-2-thione derivatives: promising anticancer agents.
Aboraia AS; Abdel-Rahman HM; Mahfouz NM; El-Gendy MA
Bioorg Med Chem; 2006 Feb; 14(4):1236-46. PubMed ID: 16242340
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and in vitro anticancer activity of novel quinoline and oxadiazole derivatives of ursolic acid.
Gu W; Jin XY; Li DD; Wang SF; Tao XB; Chen H
Bioorg Med Chem Lett; 2017 Sep; 27(17):4128-4132. PubMed ID: 28733083
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and anti-tumor evaluation of novel steroidal glycoconjugate with furoxan derivatives.
Li H; Wang K; Wan Q; Chen Y
Steroids; 2019 Jan; 141():81-95. PubMed ID: 30521816
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro antiproliferative activity of new 1,3,4-oxadiazole derivatives possessing sulfonamide moiety.
Gamal El-Din MM; El-Gamal MI; Abdel-Maksoud MS; Yoo KH; Oh CH
Eur J Med Chem; 2015 Jan; 90():45-52. PubMed ID: 25461310
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anticancer evaluation of new lipophilic 1,2,4 and 1,3,4-oxadiazoles.
Caneschi W; Enes KB; Carvalho de Mendonça C; de Souza Fernandes F; Miguel FB; da Silva Martins J; Le Hyaric M; Pinho RR; Duarte LM; Leal de Oliveira MA; Dos Santos HF; Paz Lopes MT; Dittz D; Silva H; Costa Couri MR
Eur J Med Chem; 2019 Mar; 165():18-30. PubMed ID: 30654237
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antitumor evaluation of novel hybrids of phenylsulfonylfuroxan and epiandrosterone/dehydroepiandrosterone derivatives.
Huang Y; Liu M; Meng L; Feng P; Guo Y; Ying M; Zhu X; Chen Y
Steroids; 2015 Sep; 101():7-14. PubMed ID: 26004429
[TBL] [Abstract][Full Text] [Related]
20. A facile synthesis of novel bis-(indolyl)-1,3,4-oxadiazoles as potent cytotoxic agents.
Kumar D; Arun V; Maruthi Kumar N; Acosta G; Noel B; Shah K
ChemMedChem; 2012 Nov; 7(11):1915-20. PubMed ID: 22997171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]